We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.03%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$160M
AUM Growth
+$18.2M
(+13%)
Cap. Flow
+$206K
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
28.13%
Holding
136
New
16
Increased
30
Reduced
10
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Takeda Pharmaceutical
TAK
|
+$748K |
| 2 |
Invesco QQQ Trust
QQQ
|
+$407K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$380K |
| 4 |
iShares Select Dividend ETF
DVY
|
+$362K |
| 5 |
SPDR Gold Trust
GLD
|
+$314K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$1.29M |
| 2 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$676K |
| 3 |
TLP
Transmontaigne
TLP
|
+$625K |
| 4 |
B&G Foods
BGS
|
+$428K |
| 5 |
Sempra
SRE
|
+$325K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Financials | 14.68% |
| 3 | Technology | 13.62% |
| 4 | Industrials | 12.48% |
| 5 | Energy | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBY
126
DELISTED
Libbey, Inc.
LBY
| $28K | 0.02% |
10,000
| – | – |
|
127
AYTU BioPharma
AYTU
$23.1M
| $25K | 0.02% |
+75
| New | +$18.7K |
|
128
Vista Gold
VGZ
$225M
| $7K | ﹤0.01% |
+10,000
| New | +$6.93K |
|
|
129
B&G Foods
BGS
$301M
| – | – |
-14,800
| Closed | -$428K |
|
130
Cleveland-Cliffs
CLF
$5.29B
| – | – |
-17,500
| Closed | -$135K |
|
131
Marathon Petroleum
MPC
$91.3B
| – | – |
-3,398
| Closed | -$201K |
|
|
132
Sempra
SRE
$60.3B
| – | – |
-6,000
| Closed | -$325K |
|
|
TLP
133
DELISTED
Transmontaigne
TLP
| – | – |
-15,400
| Closed | -$625K |
|
|
ATVI
134
DELISTED
Activision Blizzard
ATVI
| – | – |
-6,400
| Closed | -$298K |
|
|
BDSI
135
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| – | – |
-182,650
| Closed | -$676K |
|
|
SHPG
136
DELISTED
Shire pic
SHPG
| – | – |
-7,390
| Closed | -$1.29M |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Searle & Co held 136 positions worth $160M, up 13% from $142M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Searle & Co's Q1 2019 filing shows 16 new, 30 increased, 10 reduced and 8 closed positions. Its largest new stake was Takeda Pharmaceutical: 37,196 shares worth $758K. The largest sale was Shire pic, an estimated $1.29M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Searle & Co's largest Q1 2019 buy was Takeda Pharmaceutical: 37,196 shares worth $758K.
- Searle & Co added most to Apple in Q1 2019, an estimated $97.7K increase.
- Searle & Co's biggest Q1 2019 reduction was Altria Group, cutting an estimated $319K.
- Searle & Co fully exited Shire pic in Q1 2019, selling an estimated $1.29M.
- Searle & Co's ten largest holdings make up 28% of its $160M portfolio in Q1 2019.
- Searle & Co opened 16 new positions and closed 8 in Q1 2019.
- Searle & Co's portfolio value rose 13% quarter-over-quarter to $160M.
Based on Searle & Co's 13F filing for Q1 2019, filed 22 Apr 2019.